Abstract:JEV infection can cause severe central nerve system disease which result in high mortality or developing permanent neurological sequelae in more than half of the survivors. The envelope (E) protein of JEV is the major antigen peptide fused to it. A recombinant hsp70 protein expression vector pPICZalpha-E-HSP70 in methylotrophic yeast Pichia pastoris was developed that permits major antigenic segment of JEV E protein fused to the amino terminus of M. tuberculosis hsp70. This core vector avoided inclusion bodies formed in Escherichia coli and complex purification. Moreover,it ruled out contamination of LPS. Two other vectors pPICZalpha-E and pPICZalpha-HSP70 were also constructed. The two vectors were constructed by routine molecular technique. All vectors were transformed into yeast X-33 by electroporation. Expression of the fusion protein in yeast was induced by the addition of methanol every 24 hours and analysed by SDS-PAGE and western blot. Major antigenic segment of E protein was produced at a yield of 290 mg per litter of culture, hsp70 protein at a yield of 178 mg per litter of culture and E-HSP70 fusion protein at a yield of 33 mg per litter of culture in methylotrophic yeast Pichia pastoris. To examine cell and body immune response after BALB/c mice were immunized with E-hsp70 fusion protein expressed in Pichia pastoris, there were three groups with ten mice in each group. 5.7 microg (50pmol) of E-hsp70 fusion protein, 2.2 microg (50pmol) major antigenic segment of E protein and a mixture of hsp70 and major antigenic segment of E protein (1:1) including 3.5 microg (50pmol) Hsp70 and 2.2 microg (50pmol) major antigenic segment of JEV E protein were used per mouse i.p. on day 0 and day 21. The production of mIL-2 was quantitated by semi-quantitative RT-PCR. Besides, proliferation of lymphocytes was measured by MTT and titers of antibody was determined by ELISA. These data show that the fusion protein is a more powerful antigen than major antigenic segment of JEV E protein. So it also illustrates the effectiveness of hsp70 in eliciting a humoral and cellular response to an attached molecule in the absence of adjuvant and affirms the potential utility of hsp70 in vaccine development.

Influence of JEV E-HSP70(Mycobacterium Tuberculosis) Fusion Protein on Immune Response in BALB/c Mice

Influence of FMDV epitopes-hsp70 fusion protein on immune responses in mice

[Fusion Expression of O Type Foot-and-mouth Diseases Virus VP1 Gene and HSP70 Gene and Induction of Immune Responses in Mice].

Heterologous Expression of FMDV Immunodominant Epitopes and HSP70 in P. Pastoris and the Subsequent Immune Response in Mice

Baculovirus Surface Display of E Envelope Glycoprotein of Japanese Encephalitis Virus and Its Immunogenicity of the Displayed Proteins in Mouse and Swine Models.

Immunization with Pseudotype Baculovirus Expressing Envelope Protein of Japanese Encephalitis Virus Elicits Protective Immunity in Mice

DNA Immunization by Recombinants Encoding Prme and E Proteins Derived from Japanese Encephalitis Virus

A plasmid encoding Japanese encephalitis virus PrM and E proteins elicits protective immunity in suckling mice.

[Hsp70 Fused with the Envelope Glycoprotein E0 of Classical Swine Fever Virus Enhances Immune Responses in Balb/c Mice]

Mutation of Putative N-linked Glycosylation Sites in Japanese Encephalitis Virus Premembrane and Envelope Proteins Enhances Humoral Immunity in BALB/C Mice after DNA Vaccination.

[The Immunization Effects of HBV Core Antigen and Surface Antigen Fusion Protein in Mice].

Expression of Japanese Encephalitis Virus E Protein in Methylotrophic Yeast Pichia Pastoris

Bursin As an Adjuvant is a Potent Enhancer of Immune Response in Mice Immunized with the JEV Subunit Vaccine.

Construction of the Recombinant Attenuated Salmonella typhimurium Live Vector Vaccine Strain Expressing JEV E Antigen and its Immunogenicity Analysis

Investigation of Immune Response Induction by Japanese Encephalitis Live‐attenuated and Chimeric Vaccines in Mice

Complete protection for mice conferred by a DNA vaccine based on the Japanese encephalitis virus P3 strain used to prepare the inactivated vaccine in China

Cellular Immunity of BALB/c Mice Induced by DNA Vaccine Encoding Prme Protein Derived from Japanese Encephalitis Virus in the Routes of Different Inoculation

Recombinant Expression of Antigen Epitope Genes of Human Cytomegalovirus and Immunogenicity Detection of the Fusion Protein

Retracted: Immunization With Pseudotype Baculovirus Expressing Envelope Protein Of Japanese Encephalitis Virus Elicits Protective Immunity In Mice (Retracted Article. See Vol 11, Pg 454, 2009)

Immunogenicity Evaluation of the Prokaryotic Expressed E2 Protein of Western Equine Encephalomyelitis Virus in Mice

Induction Of Specific Humoral And Cellular Immune Responses In A Mouse Model Following Gene Fusion Of Hsp70c And Hantaan Virus Gn And S0.7 In An Adenoviral Vector